Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Agnelli

Showing results (41-50 of 202) with videos related to

Pageof 21
Sort By:
Thrombosis Research|September 25, 2001
Risk factors for adverse short-term outcome in patients with pulmonary embolismC Becattini, G Agnelli
Postgraduate Medical Journal|December 1, 1980
Mucus-secreting 'signet-ring' cells in CSF revealing the site of primary cancerG Agnelli, P Gresele
Recenti Progressi in Medicina|April 20, 1999
[New antithrombotic drugs]M R Taliani, G Agnelli
Thrombosis Research. Supplement|January 1, 1990
Clinical experience with low molecular weight heparinsG G Nenci, G Agnelli
Lancet (London, England)|June 25, 1977
Effect of distress on factor-VIII activityG G Nenci, G Agnelli
Journal of Thrombosis and Haemostasis : JTH|January 7, 2005
Spiral computed tomography is the first-line chest imaging test for acute pulmonary embolism: noP W Kamphuisen, G Agnelli
Molecular Biology & Medicine|April 1, 1991
Strategies for administration of tissue plasminogen activatorE J Topol, G Agnelli
Journal of Thrombosis and Haemostasis : JTH|May 12, 2010
Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studiesM Verso, G Gussoni, G Agnelli
Seminars in Thrombosis and Hemostasis|April 6, 2001
End points in studies on the prevention of deep vein thrombosisF Sonaglia, R Rossi, G Agnelli
Thrombosis and Haemostasis|February 12, 1998
Choice of end-points in assessing the efficacy of post-discharge prophylaxis for venous thromboembolismA Alatri, A Iorio, G Agnelli
Pageof 21

Showing results (41-50 of 202) with videos related to

Sort By:
Pageof 21
Thrombosis Research|September 25, 2001
Risk factors for adverse short-term outcome in patients with pulmonary embolismC Becattini, G Agnelli
Postgraduate Medical Journal|December 1, 1980
Mucus-secreting 'signet-ring' cells in CSF revealing the site of primary cancerG Agnelli, P Gresele
Recenti Progressi in Medicina|April 20, 1999
[New antithrombotic drugs]M R Taliani, G Agnelli
Thrombosis Research. Supplement|January 1, 1990
Clinical experience with low molecular weight heparinsG G Nenci, G Agnelli
Lancet (London, England)|June 25, 1977
Effect of distress on factor-VIII activityG G Nenci, G Agnelli
Journal of Thrombosis and Haemostasis : JTH|January 7, 2005
Spiral computed tomography is the first-line chest imaging test for acute pulmonary embolism: noP W Kamphuisen, G Agnelli
Molecular Biology & Medicine|April 1, 1991
Strategies for administration of tissue plasminogen activatorE J Topol, G Agnelli
Journal of Thrombosis and Haemostasis : JTH|May 12, 2010
Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studiesM Verso, G Gussoni, G Agnelli
Seminars in Thrombosis and Hemostasis|April 6, 2001
End points in studies on the prevention of deep vein thrombosisF Sonaglia, R Rossi, G Agnelli
Thrombosis and Haemostasis|February 12, 1998
Choice of end-points in assessing the efficacy of post-discharge prophylaxis for venous thromboembolismA Alatri, A Iorio, G Agnelli
Pageof 21